4.5 Article

Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization

Journal

SCIENCE SIGNALING
Volume 11, Issue 539, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scisignal.aas9609

Keywords

-

Funding

  1. Deutsche Forschungsgemeinschaft grant [SFB/TR166-TPC5]
  2. Monash Fellowship
  3. National Health and Medical Research Council (NHMRC) RD Wright Fellowship [1061687]
  4. NHMRC project grant [1121029]
  5. National Health and Medical Research Council of Australia [1121029] Funding Source: NHMRC

Ask authors/readers for more resources

G protein receptor kinases (GRKs) and beta-arrestins are key regulators of mu-opioid receptor (MOR) signaling and trafficking. We have previously shown that high-efficacy opioids such as DAMGO stimulate a GRK2/3-mediated multisite phosphorylation of conserved C-terminal tail serine and threonine residues, which facilitates internalization of the receptor. In contrast, morphine-induced phosphorylation of MOR is limited to Ser(375) and is not sufficient to drive substantial receptor internalization. We report how specific multisite phosphorylation controlled the dynamics of GRK and beta-arrestin interactions with MOR and show how such phosphorylation mediated receptor desensitization. We showed that GRK2/3 was recruited more quickly than was beta-arrestin to a DAMGO-activated MOR. beta-Arrestin recruitment required GRK2 activity and MOR phosphorylation, but GRK recruitment also depended on the phosphorylation sites in the C-terminal tail, specifically four serine and threonine residues within the (370)TREHPSTANT(379) motif. Our results also suggested that other residues outside this motif participated in the initial and transient recruitment of GRK and beta-arrestins. We identified two components of high-efficacy agonist desensitization of MOR: a sustained component, which required GRK2-mediated phosphorylation and a potential soluble factor, and a rapid component, which was likely mediated by GRK2 but independent of receptor phosphorylation. Elucidating these complex receptor-effector interactions represents an important step toward a mechanistic understanding of MOR desensitization that leads to the development of tolerance and dependence.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Spider Venom Peptide Pn3a Inhibition of Primary Afferent High Voltage-Activated Calcium Channels

Jeffrey R. McArthur, Nehan R. Munasinghe, Rocio K. Finol-Urdaneta, David J. Adams, Macdonald J. Christie

Summary: Research has shown that Pn3a produces analgesic effects by inhibiting HVA Ca(v), with enhanced inhibition observed when co-administered with opioid agonists.

FRONTIERS IN PHARMACOLOGY (2021)

Article Biochemistry & Molecular Biology

Glycosylation Regulates N-Terminal Proteolysis and Activity of the Chemokine CCL14

Siyao Wang, Simon R. Foster, Julie Sanchez, Leo Corcilius, Mark Larance, Meritxell Canals, Martin J. Stone, Richard J. Payne

Summary: The research demonstrates that glycosylation of CCL14 may influence its biological activity, especially with sialylated variants of CCL14(1-74) showing reduced activity when treated with plasmin.

ACS CHEMICAL BIOLOGY (2021)

Article Medicine, Research & Experimental

Serotonin-induced vascular permeability is mediated by transient receptor potential vanilloid 4 in the airways and upper gastrointestinal tract of mice

Jeffri S. Retamal, Megan S. Grace, Larissa K. Dill, Paulina Ramirez-Garcia, Scott Peng, Arisbel B. Gondin, Felix Bennetts, Sadia Alvi, Pradeep Rajasekhar, Juhura G. Almazi, Simona E. Carbone, Nigel W. Bunnett, Thomas P. Davis, Nicholas A. Veldhuis, Daniel P. Poole, Peter McIntyre

Summary: Serotonin (5-HT) mediates tissue edema and inflammation via the 5-HT2A receptor, TRPV4 activation, and neuropeptide release. Endothelial and epithelial cells act as physical barriers modulating fluid and molecule exchange, influenced by GPCR and ion channel signaling.

LABORATORY INVESTIGATION (2021)

Editorial Material Neurosciences

Opioid overdose and tolerance: is the recruitment of β-arrestin to the μ-receptor involved?

Alexander Gillis, Macdonald J. Christie

NEUROPSYCHOPHARMACOLOGY (2021)

Review Pharmacology & Pharmacy

Experimental considerations for the assessment of in vivo and in vitro opioid pharmacology

Rob Hill, Meritxell Canals

Summary: Morphine and other opioids are widely used for pain treatment, but their side effects limit their use. Developing opioids with fewer side effects is a major research focus, but translating promising candidates from the lab to the clinic remains challenging.

PHARMACOLOGY & THERAPEUTICS (2022)

Article Gastroenterology & Hepatology

Positive allosteric modulation of endogenous delta opioid receptor signaling in the enteric nervous system is a potential treatment for gastrointestinal motility disorders

Jesse J. DiCello, Simona E. Carbone, Ayame Saito, Vi Pham, Agata Szymaszkiewicz, Arisbel B. Gondin, Sadia Alvi, Kiliana Marique, Priyank Shenoy, Nicholas A. Veldhuis, Jakub Fichna, Meritxell Canals, Arthur Christopoulos, Celine Valant, Daniel P. Poole

Summary: This study investigates the modulation of delta opioid receptor in the enteric nervous system using allosteric modulators, demonstrating the potential of positive allosteric modulation as a pharmacological approach to enhance opioid receptor signaling and suppress colonic motility. The findings suggest that allosteric modulation of opioid receptor signaling could be a therapeutic strategy for conditions such as irritable bowel syndrome.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2022)

Article Biochemistry & Molecular Biology

αO-Conotoxin GeXIVA isomers modulate N-type calcium (CaV2.2) channels and inwardly-rectifying potassium (GIRK) channels via GABAB receptor activation

Arsalan Yousuf, Xiaosa Wu, Anuja R. Bony, Mahsa Sadeghi, Yen-Hua Huang, David J. Craik, David J. Adams

Summary: alpha O-Conotoxin GeXIVA, derived from the venom of marine snail Conus generalis, has analgesic activity and acts on GABA(B) receptors, indicating a potential important receptor target for mediating analgesia. The peptide has different structural isomers, with the bead isomer being the most potent at nicotinic acetylcholine receptors.

JOURNAL OF NEUROCHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Selective G protein signaling driven by substance P-neurokinin receptor dynamics

Julian A. Harris, Bryan Faust, Arisbel B. Gondin, Marc Andre Damgen, Carl-Mikael Suomivuori, Nicholas A. Veldhuis, Yifan Cheng, Ron O. Dror, David M. Thal, Aashish Manglik

Summary: The neuropeptide substance P activates the neurokinin-1 receptor through interactions deep within the receptor, while interactions between the neuropeptide and the receptor extracellular loops regulate G protein signaling selectivity. This study sheds light on how different stimuli can lead to distinct G protein signaling at the same receptor.

NATURE CHEMICAL BIOLOGY (2022)

Article Pharmacology & Pharmacy

The respiratory depressant effects of mitragynine are limited by its conversion to 7-OH mitragynine

Rob Hill, Andrew C. Kruegel, Jonathan A. Javitch, J. Robert Lane, Meritxell Canals

Summary: The study found differential effects of Mitragynine and its metabolite, 7-OH Mitragynine, on mouse respiration and anti-nociception. Mitragynine showed a ceiling effect on respiratory depression, while 7-OH Mitragynine had dose-dependent effects. Inhibition of CYP3A reduced the respiratory depressant effects and anti-nociception induced by Mitragynine, but had no effect on the effects of 7-OH Mitragynine. These findings suggest that metabolic saturation may contribute to the improved safety profile of Mitragynine.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Pharmacology & Pharmacy

A 4/8 Subtype α-Conotoxin Vt1.27 Inhibits N-Type Calcium Channels With Potent Anti-Allodynic Effect

Shuo Wang, Peter Bartels, Cong Zhao, Arsalan Yousuf, Zhuguo Liu, Shuo Yu, Anuja R. Bony, Xiaoli Ma, Qin Dai, Ting Sun, Na Liu, Mengke Yang, Rilei Yu, Weihong Du, David J. Adams, Qiuyun Dai

Summary: A novel alpha-conotoxin, Vt1.27, was identified from Conus vitulinus in the South China Sea, showing inhibitory effects on rat alpha 3 beta 2 nAChR subtype and Ca(V)2.2 calcium channels. Specific residues were found to significantly contribute to its inhibitory activity. It also exhibited potent anti-allodynic effect in pain models.

FRONTIERS IN PHARMACOLOGY (2022)

Article Anesthesiology

The Antinociceptive Activity of (E)-3-(thiophen-2-yl)-N-(p-tolyl)acrylamide in Mice Is Reduced by (E)-3-(furan-2-yl)-N-methyl-N-(p-tolyl)acrylamide Through Opposing Modulatory Mechanisms at the & alpha;7 Nicotinic Acetylcholine Receptor

Hugo R. Arias, Han-Shen Tae, Laura Micheli, Arsalan Yousuf, Dina Manetti, Maria Novella Romanelli, Carla Ghelardini, David J. Adams, Lorenzo Di Cesare Mannelli

Summary: The study aimed to characterize the pharmacological and behavioral activity of two novel compounds, DM497 and DM490. It was found that DM497 could relieve neuropathic pain induced by oxaliplatin, while DM490 inhibited its effect at the same dose. These effects were not associated with changes in motor coordination or locomotor activity.

ANESTHESIA AND ANALGESIA (2023)

Article Pharmacology & Pharmacy

Assessment of the potential of novel and classical opioids to induce respiratory depression in mice

Rob Hill, Julie Sanchez, Laura Lemel, Mirjana Antonijevic, Yselkla Hosking, Shailesh N. Mistry, Andrew C. Kruegel, Jonathan A. Javitch, J. Robert Lane, Meritxell Canals

Summary: This study evaluated the effects of three novel opioids on respiratory depression and analgesia, and compared these measurements with their in vitro efficacy. The results showed that these opioids can induce respiratory depression and analgesia at certain doses, but there are differences in potency and duration of effect among the novel opioids.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Meeting Abstract Cell & Tissue Engineering

Biomaterials as an ECM for in vitro models

Mitchell St Clair-Glover, Amy Hulme, Sara Miellet, Rocio Finol-Urdaneta, Arsalan Yousuf, David Adams, Zhilian Yue, Gordon Wallace, Mirella Dottori, Mirella Dottori

TISSUE ENGINEERING PART A (2022)

Article Biochemistry & Molecular Biology

A lipid-anchored neurokinin 1 receptor antagonist prolongs pain relief by a three-pronged mechanism of action targeting the receptor at the plasma membrane and in endosomes

Quynh N. Mai, Priyank Shenoy, Tim Quach, Jeffri S. Retamal, Arisbel B. Gondin, Holly R. Yeatman, Luigi Aurelio, Joshua W. Conner, Daniel P. Poole, Meritxell Canals, Cameron J. Nowell, Bim Graham, Thomas P. Davis, Stephen J. Briddon, Stephen J. Hill, Christopher J. H. Porter, Nigel W. Bunnett, Michelle L. Halls, Nicholas A. Veldhuis

Summary: The study found that the NK1R antagonist Span-Chol has a prolonged analgesic effect mechanism: increasing local concentration at membranes, sustained decrease in NK1R endocytosis, and persistent inhibition of signaling from endosomes.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

No Data Available